AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVEuropean HIV Clinical Forum 2016Clinical Case Presentations – How to manage drug - drug interactions - the practice | Anna Maria Geretti, MD, PhD, FRCPathView Video
GDPGiovanni Di PerriMD, PhDVideoHIVEuropean HIV Clinical Forum 2016How to manage drug - drug interactions - the theory | Giovanni Di Perri, MD, PhDView Video
CVFCourtney V. FletcherPharmDVideoHIVEuropean HIV Clinical Forum 2016Impact on: Pharmacology – penetration to sanctuary sites and drug-drug interactions | Courtney Fletcher, PharmDView Video
DKDaniel KuritzkesMDVideoHIVEuropean HIV Clinical Forum 2016Impact on: Virology/Resistance | Daniel Kuritzkes, MDView Video
VideoHIVEuropean HIV Clinical Forum 2016Impact on: Adherence/tolerability | Ian McGowan, MB, ChB, DPhil, MD, FRCPView Video
GDPGiovanni Di PerriMD, PhDSlidesetHIVEuropean HIV Clinical Forum 2016How to manage drug - drug interactions - the theory - Giovanni Di Perri, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2016Maintenance Therapy with Dolutegravir/Rilpivirin is efficient and well tolerated in a real-life setting - Katharina Grabmeijer PfistershammerView Slideset
JAJose ArribasMDSlidesetHIVEuropean HIV Clinical Forum 2016Clinical Case Presentations - Experience with Induction-Maintenance Therapy in real life settings - José Arribas, MDView Slideset
PCPedro CahnMD, PhDSlidesetHIVEuropean HIV Clinical Forum 2016Induction-Maintenance ARV Therapy: Why, Who, When and How? - Pedro Cahn, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2016Switching from combination antiretroviral therapy (cART) to dolutegravir (DTG) monotherapy in virologically suppressed HIV-1 infected adults: a randomized multicenter, non-inferiority clinical trial (DOMONO) - Ingeborg WijtingView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2016Lamivudine plus either Atazanavir/ritonavir, Darunavir/ritonavir or Dolutegravir as switch strategies in HIV-positive, virologically-suppressed patients: a comparison - Alberto BorghettiView Slideset
DDDiane DescampsMD, PHDSlidesetHIVEuropean HIV Clinical Forum 2016Virological response of HIV-infected-patients virologically-suppressed switching to a DTG-based regimen in an observational cohort based on the genotypic susceptibility score - Diane DescampsView Slideset
